CorMedix Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

CorMedix Stock Summary

CorMedix competes with Tarsus Pharmaceuticals, Aldeyra, Travere Therapeutics, Eton Pharmaceuticals, and Precigen. CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey. Cormedix operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 29 people.

CorMedix Key Financial Ratios

CorMedix Key Balance Sheet Accounts

CorMedix Key Income Statement Accounts

CorMedix Key Cash Accounts

CorMedix Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining CorMedix's current stock value. Our valuation model uses many indicators to compare CorMedix value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CorMedix competition to find correlations between indicators driving CorMedix's intrinsic value. More Info.CorMedix is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, CorMedix's Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value CorMedix by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

CorMedix Systematic Risk

Today, most investors in CorMedix Stock are looking for potential investment opportunities by analyzing not only static indicators but also various CorMedix's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of CorMedix growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of CorMedix help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of CorMedix. We use our internally-developed statistical techniques to arrive at the intrinsic value of CorMedix based on widely used predictive technical indicators. In general, we focus on analyzing CorMedix Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CorMedix's daily price indicators and compare them against related drivers.

When running CorMedix's price analysis, check to measure CorMedix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CorMedix is operating at the current time. Most of CorMedix's value examination focuses on studying past and present price action to predict the probability of CorMedix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CorMedix's price. Additionally, you may evaluate how the addition of CorMedix to your portfolios can decrease your overall portfolio volatility.